3.795USD+7.66%Mkt Cap: 2.00B USDP/E: —Last update: 2026-06-01
Recursion Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in the decoding biology and chemistry by integrating technological innovations across biology, chemistry, automation, data science, and eng…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap2.00B USD
Enterprise Value1.31B USD
Revenue (TTM)66.41M USD
Gross Profit3.30M USD
Net Income (TTM)-644.76M USD
Revenue/Share0.1390 USD
Last Price3.795 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees600
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-4.09
PEG—
EV/EBITDA-2.62
EV/Revenue19.80
P/S28.69
P/B1.86
EPS (TTM)-1.16
EPS (Forward)-0.88
52W Range
2.77023% of range7.180
52W High7.180 USD
52W Low2.770 USD
Profitability
Gross Margin4.45%
Oper. Margin-1985.55%
EBITDA Margin0.00%
Profit Margin-868.29%
ROE-57.01%
ROA-43.74%
Growth
Revenue Growth-56.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF-371.81M USD
CapEx (TTM)8.63M USD
FCF Margin-267.73%
FCF Yield-8.90%
Net Debt-582.10M USD
Net Debt/EBITDA1.16
Balance Sheet
Debt/Equity0.07
Current Ratio5.47
Quick Ratio5.15
Book Value/Sh1.931 USD
Cash/Share1.235 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating2.5 (Hold)
Target (Mean)6.643 USD
Target Range3.000 USD – 10.00 USD
# Analysts7
Ownership
Shares Out.524.68M
Float512.75M
Insiders2.27%
Institutions68.64%
Short Interest
Short Ratio14.3d
Short % Float36.84%
Short % Out.34.75%
Shares Short184.44M
Short (prev mo.)174.40M
Technical
SMA 503.277 (+15.8%)
SMA 2004.284 (-11.4%)
Beta1.05
S&P 52W Chg27.70%
Avg Vol (30d)14.62M
Avg Vol (10d)18.85M
Technical Indicators
RSI (14)60.0
MACD-0.0382
MACD Signal-0.0878
MACD Hist.+0.0496
BB Upper3.608 USD
BB Middle3.177 USD
BB Lower2.746 USD
BB Width27.15%
ATR (14)0.2181 USD
Vol Ratio (20d)1.54x